ukmla MCQ (SBA): HFrEF disease-modifying therapy

Instant feedback + full explanation. One question, done properly.

MediumCardiologyHFrEF disease-modifying therapyukmlamrcp part 1mrcgp aktpane

A 72-year-old woman with heart failure with reduced EF is on ACE inhibitor and beta-blocker. Which additional class improves mortality?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

ukmla MCQ: HFrEF disease-modifying therapy — Answer & Explanation | ia